ArticleMolecules (Basel, Switzerland)2021
Expanding the Chemical Space of Benzimidazole Dicationic Ionic Liquids.
Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 18 citations in OpenAlex.
- Dicationic ionic liquids as green functional materials.RSC advances · 2026Review
- A Novel Approach for the Preparation of Tetrathionate Ionic Liquids and Study of Their Sulfur Dissolution Properties.International journal of molecular sciences · 2025Article
- Effect of Alkyl Chain Length on Dissolution and Regeneration Behavior of Cotton in 1-Alkyl-3-methylimidazolium Acetate Ionic Liquids.Molecules (Basel, Switzerland) · 2025Article
- Ionic Liquids as Starch Plasticizers: The State of the Art.Molecules (Basel, Switzerland) · 2025Review
- A Combined Experimental/Computational Study of Dicationic Ionic Liquids with Bromide and Tungstate Anions.Molecules (Basel, Switzerland) · 2024Article
- Experimental and Simulation Studies of Imidazolium Chloride Ionic Liquids with Different Alkyl Chain Lengths for Viscosity Reductions in Heavy Crude Oil: The Effect on Asphaltene Dispersion.Molecules (Basel, Switzerland) · 2024Article
- Synthesis and physical properties of tunable aryl alkyl ionic liquids based on 1-aryl-4,5-dimethylimidazolium cations.Beilstein journal of organic chemistry · 2024Article
- A comparative study on the design and application of new nano benzimidazolium gemini ionic liquids for curing interfacial properties of the crude oil-water system.RSC advances · 2023Article
- Investigation of HMolecules (Basel, Switzerland) · 2022Article
- A Specific Interaction between Ionic Liquids' Cations and Reichardt's Dye.Molecules (Basel, Switzerland) · 2022Article
- Recent Advances in Imidazolium-Based Dicationic Ionic Liquids as Organocatalysts: A Mini-Review.Materials (Basel, Switzerland) · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Benzimidazole dicationic ionic liquids (BDILs) have not yet been widely explored in spite of their potential. Therefore, two structurally related families of BDILs, paired with either bromide or bistriflimide anions and bearing alkyl spacers ranging from C3 to C6, have been prepared. Their thermal properties have been studied by thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC), while their electrical properties have been assessed by cyclic voltammetry (CV). TG analysis confirmed the higher stability of the bistriflimide BDILs over the bromide BDILs, with minor variation within the two families. Conversely, DSC and CV allowed for ascertaining the role played by the spacer length. In particular, the thermal behavior changed dramatically among the members of the bistriflimide family, and all three possible thermal behavior types of ILs were observed. Furthermore, cyclic voltammetry showed different electrochemical window (C
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.